Posts by everest

Vaccine development targeting same protein complex as KB-001 Mab.

Two Companion of diagnostics -one for genotyping the bacteria and one for measuring the toxic vesicles in the blood. — in development.

Humanized chimeric monoclonal antibody candidates with similar binding to Porphyromonas gingivalis, ready for drug development.

Monoclonal antibody with unique binding to P. gingivalis toxin/survival complex KB-001 has already been shown in its first clinical study to prevent long term recolonization, thereby eliminating all of the virulence factors of P.g. contributing to systemic/organ-based inflammation at their source.